贝贝 于

Dr. 贝贝 于


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2025 in Nature Aging
Verified
Journal Article
Open access
PDF file
YHYiming Hao
Yiming Hao
贝于贝贝 于
贝贝 于
MQMingze Qin
Mingze Qin
TQTao Qin
Tao Qin
JWJianhong Wang
Jianhong Wang
JHJinghui Huang
Jinghui Huang
Antler blastema progenitor cells (ABPCs) are a distinct population of skeletal mesenchymal stem cells found in regenerating deer antlers, with strong stemness and renewal capacity in vitro. Stem cell-derived extracellular vesicles (EVs) are emerging as potential therapeutic candidates that can mediate donor cells’ beneficial effects. Here, we tested the effects of ABPC-derived EVs (EVsABPC) on aging in mice and rhesus macaques (Macaca mulatta). We identified a variety of unique factors in EVsABPC and showed that in vitro, EVsABPC attenuated phenotypes of senescence in bone marrow stem cells. In aged mice and macaques, EVsABPC substantially increased femoral bone mineral density. Further, intravenous EVsABPC improved physical performance, enhanced cognitive function and reduced systemic inflammation in aged mice, while reversing epigenetic age by over 3 months. In macaques, EVABPC treatment was also neuroprotective, reduced inflammation, improved locomotor function and reduced epigenetic age by over 2 years. Our findings position ABPCs as an emerging and practical source of EVs with translational value for healthy aging interventions.

1 October 2025 in iScience
Verified
Journal Article
Open access
ZWZide Wang
Zide Wang
ZMZhe Meng
Zhe Meng
YLYaosai Liu
Yaosai Liu
BSBoyan Su
Boyan Su
GLGuoxi Luan
Guoxi Luan
WMWeitao Man
Weitao Man
Microglia represent critical therapeutic targets in spinal cord injury (SCI), with damage-associated microglia (DAM) playing key roles in neuroinflammation and tissue repair. Through integrated in-silico analysis of single-cell RNA sequencing (scRNA-seq) and microarray datasets, we identified DAM subsets specific to acute SCI characterized by hub genes Fcer1g, Grn, and Gusb. Using a C57BL/6 mouse spinal cord contusion model, we validated increased DAM accumulation post-injury and demonstrated their propensity to transition toward homeostatic microglia (MG2). Eupatilin treatment promoted DAM-to-MG2 differentiation, as confirmed through bulk and scRNA-seq analyses, revealing supportive gene expression changes. These findings establish DAM as functionally distinct microglial populations in acute SCI and identify Eupatilin as a therapeutic agent that facilitates beneficial microglial polarization. This work provides mechanistic insights into microglial dynamics during SCI and suggests targeted modulation of DAM-to-MG2 transitions as a promising therapeutic strategy for promoting inflammation resolution and functional recovery.

1 July 2021 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
贝于贝贝 于
贝贝 于
JLJiatong Li
Jiatong Li
LJLinkai Jing
Linkai Jing
WMWeitao Man
Weitao Man
GWGui Huai Wang
Gui Huai Wang

10 May 2022
Verified
Report
Closed access
XSXi’an Jiaotong University School
Xi’an Jiaotong University School
贝于贝贝 于
贝贝 于
YZYongfeng Zhang
Yongfeng Zhang
SGShouping Gong
Shouping Gong
Review question / Objective: The purpose of this study was to investigate the effect of miRNA-modified exosomes in alleviating cerebral ischemic reperfusion injury compared with the non-treatment group. The research object is an animal model of middle cerebral artery occlusion. The research method is a controlled study. The primary outcome of this study was infarct volume, and the secondary outcome was neurobehavioral performance. Main outcome(s): The primary outcome of this study was Infarct volumes,which was measured by 2,3,5-triphenyltetranzolium chloride (TTC) staining. And it was calculated as followed: Infarct volume % = lesion area of each section = (contralateral hemisphere area/ipsilateral hemisphere area) × ipsilateral lesion area. Neurobehavioral performance was the secondary outcome, and was assessed by three scoring scales: modified neurological severity score (mNSS), Longa scoring system and neurological deficit score (NDS).